copy and paste this google map to your website or blog!
Press copy button and paste into your blog or website.
(Please switch to 'HTML' mode when posting into your blog. Examples: WordPress Example, Blogger Example)
Input Form:Deal with this potential dealer,buyer,seller,supplier,manufacturer,exporter,importer
(Any information to deal,buy, sell, quote for products or service)
PowerPoint Presentation What is the TOUCH Prescribing Program designed to do? To inform prescribers, infusion site, healthcare providers, and patients about the risk of progressive multifocal leukoencephalopathy (PML) associated with TYSABRI® including the increased risk of PML with the presence of anti-JCV antibodies, longer treatment duration, and prior
TOUCH On-Line Presentation to provide education necessary to execute TOUCH Prescribing Program, intended for prescribers, infusion sites, and certified pharmacies TOUCH Prescribing Program Educational Slide Set
TOUCH On-Line To learn more about enrolling in the TOUCH Prescribing Program, contact a TYSABRI Support Specialist at Biogen, call toll free: 1-800-456-2255 Monday-Friday, 8:30 AM to 8:00 PM (ET)
Overview of the TOUCH Program TOUCH On-Line is a web-based tool designed to: Provide real-time access to TYSABRI patient data Maintain compliance with the TOUCH Prescribing Program Reduce administrative burden paperwork for prescribers and infusion sites TOUCH On-Line is accessed with secure username and password
TOUCH On-Line The TOUCH Prescribing Program is designed to: Inform prescribers, infusion center healthcare providers, and patients about the risk of progressive multifocal leukoencephalopathy (PML) associated with TYSABRI including the increased risk of PML with treatment duration and prior immunosuppressant use
GUÍA DEL MEDICAMENTO - touchprogram. com TYSABRI® (natalizumab) Lea la Guía del Medicamento antes de comenzar a usar TYSABRI y antes de cada infusión Puede haber información nueva Esta Guía del Medicamento no reemplaza una conversación con el médico acerca de su condición médica o su tratamiento Si tiene alguna pregunta, hágasela al médico o al personal de enfermería
Understanding PML for Gastroenterologists For prescribers and patients, the TOUCH® Prescribing Program has two components: MS TOUCH® (for patients with multiple sclerosis) and CD TOUCH® (for patients with Crohn’s disease)
Please see the Prescribing Information, including BOXED WARNING, What is the TOUCH Prescribing Program designed to do? To inform prescribers, infusion site, healthcare providers, and patients about the risk of progressive multifocal leukoencephalopathy (PML) associated with TYSABRI® including the increased risk of PML with the presence of anti-JCV antibodies, longer treatment duration, and prior
Helpful information for evaluation of new neurological symptoms in . . . As part of the TOUCH Prescribing Program: • Physicians evaluate patients 3 months after the first infusion, 6 months after the first infusion, every 6 months thereafter to determine whether patients should continue on treatment, and for at least 6 months after discontinuing TYSABRI • Physicians submit the TYSABRI Patient Status Report and
Para obtener más información, llama al Guía del Medicame Informa a todos tus médicos que estás recibiendo un tratamiento con TYSABRI Debido a tu riesgo de contraer LMP mientras recibes un tratamiento con TYSABRI, TYSABRI está disponible únicamente a través de un programa de distribución con restricciones llamado Programa de Prescripción TOUCH®